³Ô¹ÏÍøÕ¾

Latest

Latest clinical study News

  • Latest clinical study news stories and updates. What is happening today? All recent clinical study news and developments. Live coverage and timeline of clinical study. All you need to know about clinical study.
Eight conditions weight-loss jabs might be beneficial for
World’s First Patent Acquired for Animal Supplement “Pinfenon” (S) (R)
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
PolyActiva Showcases Promising Clinical Data Highlighting its Polymer Technology’s Potential to Transform Glaucoma Care
Foundation Grant Boosts Breast Cancer Research
TGA’s Decision To Not Register Lecanemab
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
KI Biobank Turns 20: “A Goldmine For Researchers”
Invion updates on Phase 2 prostate cancer trial of INV043
Top Perth Leukaemia Researcher Wins Prestigious Award
Vaxxas initiates Phase 1 clinical trial of pre-pandemic Avian Influenza A Virus vaccine
Biotron updates on BIT225-012 Phase 2 COVID-19 clinical trial
Duloxetine may help elderly with depression and cognitive impairment
Aceneuramic Acid is the First Approved Drug for GNE Myopathy Treatment
ZEISS Adopts PolyU’s Patented Technology to Develop ZEISS MyoCare Myopia Control Lenses for Children; Professional ophthalmic products feature patented myopia control technology,…
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
Detecting Lung Cancer With Nanotech
Further Transparency Needed In Cancer Clinical Trials
Perineal Cut Reduces Risk Of Serious Birth Injury
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Aged Care Study To Test Virus Fighting Technology
More research supports androgen treatment for breast cancer
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Immutep appoints research institute to conduct first-in-human study of IMP761
Diabetes Australia kicks off partnership with Defeat Diabetes
Dimerix raises $20 million to continue and expand late-stage clinical trial of DMX-200
Pilot Program For Gambling
Biomedical grants set to bring new projects to Queensland
Strongest contender in decades in fight against breast cancer
Vaccine shows promise against CMV, a virus that causes birth defects
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Starpharma says Viraleze shows antiviral efficacy in COVID-19 patients
Microba Life Sciences announces results of successful Phase IBD trial
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
AdAlta reports favourable patient tolerability after third dose in AD-214 extension study
Support for heavy gamblers through family intervention
Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
Inside AMD study
Adrenocortical carcinoma: No mitotane for low risk of recurrence
Study suggests flu vaccine may take edge off respiratory virus
Multi-million dollar funding boost for BioSpine
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
Starpharma announces that Viraleze approved in Malaysia

© 2024 - ³Ô¹ÏÍøÕ¾